CN1330935A - Drug-dropping Chinese patent medicine for improving immunity of human body itself - Google Patents
Drug-dropping Chinese patent medicine for improving immunity of human body itself Download PDFInfo
- Publication number
- CN1330935A CN1330935A CN00113082A CN00113082A CN1330935A CN 1330935 A CN1330935 A CN 1330935A CN 00113082 A CN00113082 A CN 00113082A CN 00113082 A CN00113082 A CN 00113082A CN 1330935 A CN1330935 A CN 1330935A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- drug
- chinese patent
- patent medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 47
- 230000036039 immunity Effects 0.000 title claims abstract description 7
- 241000208340 Araliaceae Species 0.000 claims abstract description 12
- 235000008434 ginseng Nutrition 0.000 claims abstract description 11
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 10
- 241000222336 Ganoderma Species 0.000 claims abstract description 8
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 8
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 8
- 229940079593 drug Drugs 0.000 claims description 27
- 241000522620 Scorpio Species 0.000 claims description 10
- 235000000126 Styrax benzoin Nutrition 0.000 claims description 10
- 239000009490 scorpio Substances 0.000 claims description 10
- 241000218176 Corydalis Species 0.000 claims description 9
- 241000255791 Bombyx Species 0.000 claims description 8
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 235000015511 Liquidambar orientalis Nutrition 0.000 claims description 8
- 239000004870 Styrax Substances 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 7
- 241000131808 Scolopendra Species 0.000 claims description 7
- 239000008517 radix Trichosanthis Substances 0.000 claims description 7
- 241000736148 Styrax Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 11
- 230000006378 damage Effects 0.000 abstract description 3
- 210000004185 liver Anatomy 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 239000002574 poison Substances 0.000 abstract 1
- 231100000614 poison Toxicity 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- 208000011117 substance-related disease Diseases 0.000 description 9
- 244000028419 Styrax benzoin Species 0.000 description 8
- 206010013654 Drug abuse Diseases 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 7
- 229960001797 methadone Drugs 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 4
- 238000001784 detoxification Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 206010013754 Drug withdrawal syndrome Diseases 0.000 description 3
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000008896 Opium Substances 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 229960002069 diamorphine Drugs 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 229960001027 opium Drugs 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 229960001736 buprenorphine Drugs 0.000 description 2
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 206010013663 drug dependence Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 241000255783 Bombycidae Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 241000239225 Buthidae Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 241001289529 Fallopia multiflora Species 0.000 description 1
- 241001489090 Ganoderma japonicum Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000142952 Hamamelidaceae Species 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 241000037831 Polygonatum sibiricum Species 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 235000016551 Potentilla erecta Nutrition 0.000 description 1
- 240000000103 Potentilla erecta Species 0.000 description 1
- 241000405911 Rehmannia glutinosa Species 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 241000131792 Scolopendridae Species 0.000 description 1
- 235000019084 Selinum monnieri Nutrition 0.000 description 1
- 244000296102 Selinum monnieri Species 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 241001060310 Styracaceae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229960002896 clonidine Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229960005209 lofexidine Drugs 0.000 description 1
- KSMAGQUYOIHWFS-UHFFFAOYSA-N lofexidine Chemical compound N=1CCNC=1C(C)OC1=C(Cl)C=CC=C1Cl KSMAGQUYOIHWFS-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 239000004084 narcotic analgesic agent Substances 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 201000009032 substance abuse Diseases 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN00113082A CN1117575C (en) | 2000-06-28 | 2000-06-28 | Drug-dropping Chinese patent medicine for improving immunity of human body itself |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN00113082A CN1117575C (en) | 2000-06-28 | 2000-06-28 | Drug-dropping Chinese patent medicine for improving immunity of human body itself |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1330935A true CN1330935A (en) | 2002-01-16 |
CN1117575C CN1117575C (en) | 2003-08-13 |
Family
ID=4582899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN00113082A Expired - Fee Related CN1117575C (en) | 2000-06-28 | 2000-06-28 | Drug-dropping Chinese patent medicine for improving immunity of human body itself |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1117575C (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103520588A (en) * | 2013-10-09 | 2014-01-22 | 樊彪彪 | A Chinese herbal medicine composition used for drug rehabilitation |
CN106266935A (en) * | 2016-08-04 | 2017-01-04 | 滨州医学院 | A kind of Chinese medicine and western medicine compound medicine for giving-up drug-taking and preparation method thereof |
CN106880796A (en) * | 2017-03-07 | 2017-06-23 | 贵州都匀市剑江药业有限公司 | Chinese medicine composition and its preparation method and application for treating tumour |
CN108379541A (en) * | 2018-05-18 | 2018-08-10 | 重庆跃龙生物制药有限公司 | Chinese medicine composition and preparation method thereof for drug rehabilitation |
-
2000
- 2000-06-28 CN CN00113082A patent/CN1117575C/en not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103520588A (en) * | 2013-10-09 | 2014-01-22 | 樊彪彪 | A Chinese herbal medicine composition used for drug rehabilitation |
CN103520588B (en) * | 2013-10-09 | 2016-06-08 | 樊彪彪 | A kind of drug rehabilitation herbal composite |
CN106266935A (en) * | 2016-08-04 | 2017-01-04 | 滨州医学院 | A kind of Chinese medicine and western medicine compound medicine for giving-up drug-taking and preparation method thereof |
CN106880796A (en) * | 2017-03-07 | 2017-06-23 | 贵州都匀市剑江药业有限公司 | Chinese medicine composition and its preparation method and application for treating tumour |
CN108379541A (en) * | 2018-05-18 | 2018-08-10 | 重庆跃龙生物制药有限公司 | Chinese medicine composition and preparation method thereof for drug rehabilitation |
Also Published As
Publication number | Publication date |
---|---|
CN1117575C (en) | 2003-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101342317B (en) | Medicament composition for treating tuberculosis and preparation method thereof | |
CN1840128A (en) | Medicine for treating cardiovascular disease | |
CN1931329A (en) | Stomatocase treating medicine | |
CN1117575C (en) | Drug-dropping Chinese patent medicine for improving immunity of human body itself | |
CN101249255B (en) | Proprietary Chinese medicine for curing children's cough and method of preparing the same | |
CN105902827A (en) | Traditional Chinese medicine composition for improving immunity of human body and preparation method thereof | |
CN104984296A (en) | Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof | |
CN104958536A (en) | Chinese medicinal composition for treating diabetes and preparation method thereof | |
CN102178780B (en) | Medicine for treating oral diseases and method for processing same into medicament | |
CN103989762B (en) | Chinese medicine composition of internal organs relieving cough and resolving phlegm and preparation method thereof is rushed down in a kind of heat clearing away | |
CN1335174A (en) | Stomatopathy and throat disease treating health care medicine and its production process | |
CN108686094B (en) | Traditional Chinese medicine for reducing blood sugar and preparation method thereof | |
CN1061264C (en) | Pure Chinese medicine for stopping drugs and its prepn. tech. | |
CN105169338A (en) | Medicine composition for treating female climacteric syndromes and preparation method thereof | |
CN1165691A (en) | Cream for relieving cough and asthma | |
CN101156892A (en) | A preparation method of active component composition of antineoplastic improving phylactic power | |
CN104491318A (en) | Traditional Chinese preparation used for treating asthma and preparation method of traditional Chinese preparation | |
CN110613797A (en) | Traditional Chinese medicine preparation for treating swollen sore throat and preparation method thereof | |
CN104606484A (en) | Traditional Chinese medicine composition for treating qi-blood deficiency and preparation method thereof | |
CN113082074B (en) | Application of caulis Spatholobi water extract and Chinese medicinal composition for treating chronic skin ulcer, and oral preparation | |
CN114949136B (en) | Traditional Chinese medicine composition for treating chronic pharyngitis and preparation method and application thereof | |
CN108159257A (en) | Treat Chinese medicine composition of chronic enteritis and preparation method thereof | |
CN105833063A (en) | Traditional Chinese medicine composition for treating chronic bronchitis | |
CN1352966A (en) | Medicine for treating tracheitis and asthma | |
CN107296906A (en) | Chinese medicine composition and its application in pneumonia treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: CAO YUQIONG Free format text: FORMER OWNER: LV HAN Effective date: 20131115 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 650225 KUNMING, YUNNAN PROVINCE TO: 655000 QUJING, YUNNAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20131115 Address after: 655000, No. 37 village, old house, Longhai village committee, anzhen village, Fuyuan Town, Fuyuan County, Yunnan, Qujing Patentee after: Cao Yuqiong Address before: Wang Qi Ying 650225 Yunnan city in Kunming Province Road No. 23 Dongsheng million rehabilitation center Patentee before: Lv Han |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20030813 Termination date: 20140628 |
|
EXPY | Termination of patent right or utility model |